Trial Profile
Non-interventional study regarding the combined topical treatment of acne vulgaris with Dipalen 1 mg/g cream or gel plus Nadixa 10 mg/g cream - NIS-057
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2019
Price :
$35
*
At a glance
- Drugs Adapalene (Primary) ; Nadifloxacin (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Therapeutic Use
- Acronyms NIS-057
- 14 Jan 2019 Status changed from not yet recruiting to completed.
- 25 Jun 2018 New trial record